Latest news

Insights

The New Playbook for Pharmaceutical Growth

Executive Summary For decades, pharmaceutical growth followed a relatively predictable formula. Companies invested heavily in research and development, advanced promising assets...
Insights

Top 10 Operational Risks in Modern Clinical Trial Management

Executive Summary Clinical trial management has become significantly more complex over the past decade. Modern studies involve larger volumes of...
Commercial

Eli Lilly Secures Global Rights to AlzeCure Alzheimer’s Drug Candidate in Deal Worth Over $1 Billion

Eli Lilly has entered into a collaboration and out-licensing agreement with AlzeCure Pharma to acquire global rights to an...
Clinical

Merck and Gilead Report Phase 3 HIV Success as Lung Cancer Trial Ends

Merck and Gilead Sciences reported positive Phase 3 results for their investigational once-weekly HIV treatment while also announcing the...
Insights

Top 10 Challenges Slowing AI Adoption in Drug Discovery

Executive Summary Artificial intelligence is widely viewed as one of...
Insights

Top 10 Data Governance Challenges Facing Life Sciences Companies

Executive Summary Data has become one of the most valuable...
Commercial

Ascidian & Lilly Pen RNA Exon Editing Agreement for Genetic Kidney Issues

Boston-based Ascidian Therapeutics has indicated that although nearly any gene may be editable, that capability alone does not justify...
Insights

Top 10 Trends Redefining the Future of Medical Affairs

Executive Summary Medical affairs is undergoing one of the most significant transformations in its history. Traditionally positioned as a bridge between...
Commercial

Travere Licenses Civorebrutinib From Everest Medicines in Deal Worth Up to $1.14 Billion

Travere Therapeutics has entered into a licensing agreement with Everest Medicines to acquire exclusive rights to the oral BTK...
Technology

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist...
Clinical

ADC Therapeutics’ Zynlonta Trial Results in Multiple Patient Deaths

A phase 3 study of ADC Therapeutics’ blood cancer...
Commercial

After a $1.2 billion deal, Innovent announces a phase 3 victory for Takeda-partnered ADC

IBA343 is an antibody-drug conjugate (ADC) that Takeda placed its major bets on last year, and the company said...
Clinical

Parabilis Plans Phase 3 Desmoid Tumor Trial for Zolucatetide as It Pursues IPO

Parabilis Medicines is preparing to advance its lead drug candidate, zolucatetide, into Phase 3 testing for desmoid tumors, with...
Insights

Top 10 Trends Redefining the Future of Medical Affairs

Executive Summary Medical affairs is undergoing one of the most significant transformations in its history. Traditionally positioned as a bridge between...
Commercial

Bayer Banks on Kerendia’s Potential in Heart Failure Space

Kerendia (finerenone), manufactured by Bayer and approved two summers...
Commercial

Mirvie Launches Preeclampsia Prevention Toolkit

Roughly one in every 12 pregnancies is estimated to...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

Regulatory

Insights

Top 10 Operational Risks in Modern Clinical Trial Management

Executive Summary Clinical trial management has become significantly more complex...
Commercial

Eli Lilly Secures Global Rights to AlzeCure Alzheimer’s Drug Candidate in Deal Worth Over $1 Billion

Eli Lilly has entered into a collaboration and out-licensing...
Clinical

Merck and Gilead Report Phase 3 HIV Success as Lung Cancer Trial Ends

Merck and Gilead Sciences reported positive Phase 3 results...
Clinical

Bial Says Goodbye to Asset Over Phase 2 Parkinson’s Failure

Bial has discontinued development of its experimental therapy for...

Research & Development

Market Access

Manufacturing

Cellares Raises $257 Million Series D to Expand Global Cell Therapy Manufacturing

Cellares has raised $257 million in a Series D...
Manufacturing

Recipharm Commissions Bengaluru Facility for Nonbacterial Beta-Lactam Tablet Manufacturing

Swedish contract development and manufacturing organization (CDMO) Recipharm has...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

The New Playbook for Pharmaceutical Growth

Executive Summary For decades, pharmaceutical growth followed a relatively predictable...
Editorial Team -